{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:08:08Z","timestamp":1764133688436},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,26]]},"DOI":"10.7759\/cureus.54925","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T11:05:31Z","timestamp":1708945531000},"source":"Crossref","is-referenced-by-count":1,"title":["Recovery of Smell and Taste in Patients With Persistent COVID-19-Related Hyposmia and Dysgeusia by Targeting Also Inflammation and Endothelial Dysfunction"],"prefix":"10.7759","author":[{"given":"Maurizio G","family":"Vento","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pedrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i2.9524","article-title":"Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report","volume":"91","author":"Gelardi M","year":"2020","unstructured":"Gelardi M, Trecca E, Cassano M, Ciprandi G. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report. Acta Biomed. 2020, 91:230-1. 10.23750\/abm.v91i2.9524","journal-title":"Acta Biomed"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao L","year":"2020","unstructured":"Mao L, Jin H, Wang M, et al.. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77:683-90. 10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06155-9","article-title":"Olfactory and gustatory abnormalities in COVID-19 cases","volume":"277","author":"Altin F","year":"2020","unstructured":"Altin F, Cingi C, Uzun T, Bal C. Olfactory and gustatory abnormalities in COVID-19 cases. Eur Arch Otorhinolaryngol. 2020, 277:2775-81. 10.1007\/s00405-020-06155-9","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2020.1379","article-title":"Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19","volume":"146","author":"Boscolo-Rizzo P","year":"2020","unstructured":"Boscolo-Rizzo P, Borsetto D, Fabbris C, et al.. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020, 146:729-32. 10.1001\/jamaoto.2020.1379","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07689-w","article-title":"Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic","volume":"280","author":"Krishnakumar HN","year":"2023","unstructured":"Krishnakumar HN, Momtaz DA, Sherwani A, et al.. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2023, 280:505-9. 10.1007\/s00405-022-07689-w","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study","volume":"71","author":"Giacomelli A","year":"2020","unstructured":"Giacomelli A, Pezzati L, Conti F, et al.. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis. 2020, 71:889-90. 10.1093\/cid\/ciaa330","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.04.006","article-title":"Features of anosmia in COVID-19","volume":"50","author":"Klopfenstein T","year":"2020","unstructured":"Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V, Zayet S. Features of anosmia in COVID-19. Med Mal Infect. 2020, 50:436-9. 10.1016\/j.medmal.2020.04.006","journal-title":"Med Mal Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien JR","year":"2020","unstructured":"Lechien JR, Chiesa-Estomba CM, De Siati DR, et al.. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020, 277:2251-61. 10.1007\/s00405-020-05965-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820934376","article-title":"Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: an international multicenter study","volume":"163","author":"Qiu C","year":"2020","unstructured":"Qiu C, Cui C, Hautefort C, et al.. Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: an international multicenter study. Otolaryngol Head Neck Surg. 2020, 163:714-21. 10.1177\/0194599820934376","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/00034894221082735","article-title":"Olfactory and gustatory dysfunction in COVID-19: a global bibliometric and visualized analysis","volume":"132","author":"Zyoud SH","year":"2023","unstructured":"Zyoud SH, Shakhshir M, Koni A, Shahwan M, Jairoun AA, Al-Jabi SW. Olfactory and gustatory dysfunction in COVID-19: a global bibliometric and visualized analysis. Ann Otol Rhinol Laryngol. 2023, 132:164-72. 10.1177\/00034894221082735","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.030","article-title":"Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis","volume":"95","author":"Agyeman AA","year":"2020","unstructured":"Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. 2020, 95:1621-31. 10.1016\/j.mayocp.2020.05.030","journal-title":"Mayo Clin Proc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13620","article-title":"Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis","volume":"45","author":"Rocke J","year":"2020","unstructured":"Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis. Clin Otolaryngol. 2020, 45:914-22. 10.1111\/coa.13620","journal-title":"Clin Otolaryngol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14440","article-title":"Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak","volume":"27","author":"Chiesa-Estomba CM","year":"2020","unstructured":"Chiesa-Estomba CM, Lechien JR, Radulesco T, Michel J, Sowerby LJ, Hopkins C, Saussez S. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020, 27:2318-21. 10.1111\/ene.14440","journal-title":"Eur J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22788","article-title":"Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view","volume":"11","author":"Huart C","year":"2021","unstructured":"Huart C, Philpott CM, Altundag A, et al.. Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view. Int Forum Allergy Rhinol. 2021, 11:1041-6. 10.1002\/alr.22788","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.12.641","article-title":"Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction","volume":"147","author":"Addison AB","year":"2021","unstructured":"Addison AB, Wong B, Ahmed T, et al.. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction. J Allergy Clin Immunol. 2021, 147:1704-19. 10.1016\/j.jaci.2020.12.641","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bjt072","article-title":"Olfactory disorders and quality of life--an updated review","volume":"39","author":"Croy I","year":"2014","unstructured":"Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life--an updated review. Chem Senses. 2014, 39:185-94. 10.1093\/chemse\/bjt072","journal-title":"Chem Senses"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bjab028","article-title":"Recovery from COVID-19-related olfactory disorders and quality of life: insights from an observational online study","volume":"46","author":"Ferdenzi C","year":"2021","unstructured":"Ferdenzi C, Bousquet C, Aguera PE, et al.. Recovery from COVID-19-related olfactory disorders and quality of life: insights from an observational online study. Chem Senses. 2021, 46:bjab028. 10.1093\/chemse\/bjab028","journal-title":"Chem Senses"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bju043","article-title":"The impact of olfactory disorders in the United Kingdom","volume":"39","author":"Philpott CM","year":"2014","unstructured":"Philpott CM, Boak D. The impact of olfactory disorders in the United Kingdom. Chem Senses. 2014, 39:711-8. 10.1093\/chemse\/bju043","journal-title":"Chem Senses"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256998","article-title":"Altered smell and taste: anosmia, parosmia and the impact of long Covid-19","volume":"16","author":"Burges Watson DL","year":"2021","unstructured":"Burges Watson DL, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: anosmia, parosmia and the impact of long Covid-19. PLoS One. 2021, 16:e0256998. 10.1371\/journal.pone.0256998","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135694","article-title":"Smell and taste disorders in COVID-19: from pathogenesis to clinical features and outcomes","volume":"748","author":"Mastrangelo A","year":"2021","unstructured":"Mastrangelo A, Bonato M, Cinque P. Smell and taste disorders in COVID-19: from pathogenesis to clinical features and outcomes. Neurosci Lett. 2021, 748:135694. 10.1016\/j.neulet.2021.135694","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06120-6","article-title":"Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence","volume":"278","author":"Mehraeen E","year":"2021","unstructured":"Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. 2021, 278:307-12. 10.1007\/s00405-020-06120-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820931820","article-title":"Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting tool-based comparative study","volume":"163","author":"Sayin \u0130","year":"2020","unstructured":"Sayin \u0130, Ya\u015far KK, Yazici ZM. Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting tool-based comparative study. Otolaryngol Head Neck Surg. 2020, 163:473-9. 10.1177\/0194599820931820","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-022-00216-7","article-title":"Olfactory and gustatory disorders in COVID-19","volume":"31","author":"Klimek L","year":"2022","unstructured":"Klimek L, Hagemann J, D\u00f6ge J, Freudelsperger L, Cuevas M, Klimek F, Hummel T. Olfactory and gustatory disorders in COVID-19. Allergo J Int. 2022, 31:243-50. 10.1007\/s40629-022-00216-7","journal-title":"Allergo J Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1714370","article-title":"A liaison between sudden sensorineural hearing loss and sARS-CoV-2 infection","volume":"120","author":"Harenberg J","year":"2020","unstructured":"Harenberg J, Jonas JB, Trecca EM. A liaison between sudden sensorineural hearing loss and sARS-CoV-2 infection. Thromb Haemost. 2020, 120:1237-9. 10.1055\/s-0040-1714370","journal-title":"Thromb Haemost"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby P","year":"2020","unstructured":"Libby P, L\u00fcscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020, 41:3038-44. 10.1093\/eurheartj\/ehaa623","journal-title":"Eur Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga Z","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, et al.. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020, 395:1417-8. 10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2021.100094","article-title":"Endothelial glycocalyx degradation during sepsis: causes and consequences","volume":"12","author":"Sullivan RC","year":"2021","unstructured":"Sullivan RC, Rockstrom MD, Schmidt EP, Hippensteel JA. Endothelial glycocalyx degradation during sepsis: causes and consequences. Matrix Biol Plus. 2021, 12:100094. 10.1016\/j.mbplus.2021.100094","journal-title":"Matrix Biol Plus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186116","article-title":"Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication","volume":"12","author":"Mensah SA","year":"2017","unstructured":"Mensah SA, Cheng MJ, Homayoni H, Plouffe BD, Coury AJ, Ebong EE. Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication. PLoS One. 2017, 12:e0186116. 10.1371\/journal.pone.0186116","journal-title":"PLoS One"},{"key":"ref29","article-title":"Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects","volume":"33","author":"Masola V","year":"2014","unstructured":"Masola V, Zaza G, Onisto M, Lupo A, Gambaro G. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. Int Angiol. 2014, 33:243-54.","journal-title":"Int Angiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311102","article-title":"Glycosaminoglycan neutralization in coagulation control","volume":"38","author":"Sobczak AI","year":"2018","unstructured":"Sobczak AI, Pitt SJ, Stewart AJ. Glycosaminoglycan neutralization in coagulation control. Arterioscler Thromb Vasc Biol. 2018, 38:1258-70. 10.1161\/ATVBAHA.118.311102","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081614","article-title":"The pharmaceutical device Prisma(\u00ae) skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing","volume":"18","author":"Belvedere R","year":"2017","unstructured":"Belvedere R, Bizzarro V, Parente L, Petrella F, Petrella A. The pharmaceutical device Prisma(\u00ae) skin promotes in vitro angiogenesis through endothelial to mesenchymal transition during skin wound healing. Int J Mol Sci. 2017, 18:1614. 10.3390\/ijms18081614","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30207","article-title":"Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2","volume":"236","author":"Belvedere R","year":"2021","unstructured":"Belvedere R, Morretta E, Pessolano E, et al.. Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2. J Cell Physiol. 2021, 236:4926-43. 10.1002\/jcp.30207","journal-title":"J Cell Physiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172894","article-title":"Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: a novel mechanism in skin wound healing","volume":"869","author":"Belvedere R","year":"2020","unstructured":"Belvedere R, Pessolano E, Porta A, et al.. Mesoglycan induces the secretion of microvesicles by keratinocytes able to activate human fibroblasts and endothelial cells: a novel mechanism in skin wound healing. Eur J Pharmacol. 2020, 869:172894. 10.1016\/j.ejphar.2019.172894","journal-title":"Eur J Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/390643","article-title":"Mesoglycan: clinical evidences for use in vascular diseases","volume":"2010","author":"Tufano A","year":"2010","unstructured":"Tufano A, Arturo C, Cimino E, Di Minno MN, Di Capua M, Cerbone AM, Di Minno G. Mesoglycan: clinical evidences for use in vascular diseases. Int J Vasc Med. 2010, 2010:390643. 10.1155\/2010\/390643","journal-title":"Int J Vasc Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0194599819859885","article-title":"Clinical practice guideline: sudden hearing loss (update)","volume":"161","author":"Chandrasekhar SS","year":"2019","unstructured":"Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al.. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019, 161:S1-S45. 10.1177\/0194599819859885","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2022.43.210107","article-title":"Treatment strategies for postviral olfactory dysfunction: a systematic review","volume":"43","author":"Helman SN","year":"2022","unstructured":"Helman SN, Adler J, Jafari A, et al.. Treatment strategies for postviral olfactory dysfunction: a systematic review. Allergy Asthma Proc. 2022, 43:96-105. 10.2500\/aap.2022.43.210107","journal-title":"Allergy Asthma Proc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/2058738418773833","article-title":"Assessment of the effect of mesoglycan in the treatment of audiovestibular disorders of vascular origin","volume":"32","author":"Neri G","year":"2018","unstructured":"Neri G, Marcelli V, Califano L. Assessment of the effect of mesoglycan in the treatment of audiovestibular disorders of vascular origin. Int J Immunopathol Pharmacol. 2018, 32:10.1177\/2058738418773833","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref38","article-title":"Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease","volume":"33","author":"Allegra C","year":"2014","unstructured":"Allegra C, Antignani PL. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease. Int Angiol. 2014, 33:407-18.","journal-title":"Int Angiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bjw061","article-title":"The association between olfaction and depression: a systematic review","volume":"41","author":"Kohli P","year":"2016","unstructured":"Kohli P, Soler ZM, Nguyen SA, Muus JS, Schlosser RJ. The association between olfaction and depression: a systematic review. Chem Senses. 2016, 41:479-86. 10.1093\/chemse\/bjw061","journal-title":"Chem Senses"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22624","article-title":"Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations","volume":"10","author":"Hura N","year":"2020","unstructured":"Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, Seal SM, Rowan NR. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020, 10:1065-86. 10.1002\/alr.22624","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/0194599816679952","article-title":"Prognosis of olfactory dysfunction according to etiology and timing of treatment","volume":"156","author":"Kim DH","year":"2017","unstructured":"Kim DH, Kim SW, Hwang SH, et al.. Prognosis of olfactory dysfunction according to etiology and timing of treatment. Otolaryngol Head Neck Surg. 2017, 156:371-7. 10.1177\/0194599816679952","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22140","article-title":"Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss","volume":"8","author":"Nguyen TP","year":"2018","unstructured":"Nguyen TP, Patel ZM. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. Int Forum Allergy Rhinol. 2018, 8:977-81. 10.1002\/alr.22140","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.708510","article-title":"Steroids and olfactory training for postviral olfactory dysfunction: a systematic review","volume":"15","author":"Yuan F","year":"2021","unstructured":"Yuan F, Huang T, Wei Y, Wu D. Steroids and olfactory training for postviral olfactory dysfunction: a systematic review. Front Neurosci. 2021, 15:708510. 10.3389\/fnins.2021.708510","journal-title":"Front Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06520-8","article-title":"Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell","volume":"278","author":"Le Bon SD","year":"2021","unstructured":"Le Bon SD, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol. 2021, 278:3113-7. 10.1007\/s00405-020-06520-8","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06285-0","article-title":"Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered","volume":"278","author":"Saussez S","year":"2021","unstructured":"Saussez S, Lechien JR, Hopkins C. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered. Eur Arch Otorhinolaryngol. 2021, 278:2187-91. 10.1007\/s00405-020-06285-0","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.515","article-title":"Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients","volume":"59","author":"Vaira LA","year":"2021","unstructured":"Vaira LA, Hopkins C, Petrocelli M, et al.. Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients. Rhinology. 2021, 59:21-5. 10.4193\/Rhin20.515","journal-title":"Rhinology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07570-w","article-title":"Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell","volume":"280","author":"Yaylac\u0131 A","year":"2023","unstructured":"Yaylac\u0131 A, Azak E, \u00d6nal A, Akt\u00fcrk DR, Karadenizli A. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell. Eur Arch Otorhinolaryngol. 2023, 280:757-63. 10.1007\/s00405-022-07570-w","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013876.pub3","article-title":"Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction","volume":"9","author":"O'Byrne L","year":"2022","unstructured":"O'Byrne L, Webster KE, MacKeith S, Philpott C, Hopkins C, Burton MJ. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2022, 9:CD013876. 10.1002\/14651858.CD013876.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13636","article-title":"Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines","volume":"46","author":"Hopkins C","year":"2021","unstructured":"Hopkins C, Alanin M, Philpott C, et al.. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol. 2021, 46:16-22. 10.1111\/coa.13636","journal-title":"Clin Otolaryngol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.15352","article-title":"Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis","volume":"4","author":"Renaud M","year":"2021","unstructured":"Renaud M, Thibault C, Le Normand F, Mcdonald EG, Gallix B, Debry C, Venkatasamy A. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw Open. 2021, 4:e2115352. 10.1001\/jamanetworkopen.2021.15352","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/223954-recovery-of-smell-and-taste-in-patients-with-persistent-covid-19-related-hyposmia-and-dysgeusia-by-targeting-also-inflammation-and-endothelial-dysfunction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T11:05:37Z","timestamp":1708945537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/223954-recovery-of-smell-and-taste-in-patients-with-persistent-covid-19-related-hyposmia-and-dysgeusia-by-targeting-also-inflammation-and-endothelial-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.54925","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}